As marijuana legalization spreads, this grower should reap the benefits.
Aphria Inc. (APHA)
From The Cheap Investor
Cannabis stocks could be one of the top investments of 2021.
For one, Jazz Pharmaceuticals said it would acquire GW Pharmaceuticals in a $7.2 billion cash and stock deal. All to strengthen its neuroscience business with GWPH’s cannabis-based epilepsy treatment.
Two, new research shows lower opioid deaths where cannabis is legal.
Three, more Americans are supportive of legalization. “Americans are more likely now than at any point in the past five decades to support the legalization of marijuana in the U.S. The 68% of U.S. adults who currently back the measure is not statistically different from last year’s 66%; however, it is nominally Gallup’s highest reading, exceeding the 64% to 66% range seen from 2017 to 2019.”
Four, Senate Democrats say cannabis reform will be higher priority. “We are committed to working together to put forward and advance comprehensive cannabis reform legislation that will not only turn the page on this sad chapter in American history, but also undo the devastating consequences of these discriminatory policies,” said Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ), as quoted by Marijuana Moment.
With those catalysts, cannabis stocks could see new highs this year.
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P’tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online.
Ian Cooper, The Cheap Investor, support@thecheapinvestor.com, February 4, 2021